Possible Case: Oral Sodium Phosphate
or OSP has allegedly been recalled for acute kidney injury and kidney failure.
Settlement: $89 Million Settlement Proposed
in Bextra, Celebrex Marketing Class Action
Possible Case: FDA
Mandates Additional Labeling for Over-the-Counter Pain Relievers
Possible Case: Cough and Cold Products Recalled
Sold on or After March 05, 2009
Settlement: Quest Diagnostics
Settles Federal Investigation for $302 Million
Possible Case: Valproate
Exposure During Pregnancy Lowers Toddlers’ IQs
Possible Case: Arrow Intra-Aortic Balloons
FDA Issues Class I Recall
Possible Case: Influend Cough and Cold Products
Recalled due to risk for Adverse Reactions
Possible Case: Destructive Behavior
Triggered by Parkinson’s Drugs
Possible Case: ZOLL AED Plus Defibrillator
Patient Deaths Prompt Recall
